Sean Brynjelsen, President & CEO at Eton Pharmaceuticals, Inc. (ETON), sold 120,000 shares at $31.88 ($3.8M) on 2026-05-28, disclosed to the SEC on 2026-05-29.
Open-market sale of $3.8M ETON by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.88 | 119,852 | $3.8M | 99.9% |
| 2 | $32.67 | 148 | $5K | 0.1% |
| Total | $31.88 avg | 120,000 | $3.8M | 100% |
| Filing → |
| ETON | BUY | 2022-09-23 | $21K | — | Filing → |
| ETON | BUY | 2021-08-20 | $43K | — | Filing → |
| ETON | BUY | 2021-06-03 | $30K | — | Filing → |